 SAN JOSE, Calif.--BUSINESS WIRE--Outset Medical, Inc. Nasdaq: OM Outset, a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, is bolstering its board of directors with the appointment of Karen Drexler. Drexler currently serves on the boards of ResMed NYSE: RMD, a 31B data-driven sleep and respiratory market leader; VIDA Diagnostics, developer of AI-powered lung intelligence and imaging solutions; and Tivic Health, a bioelec 